대한한방부인과학회지 (The Journal of Korean Obstetrics and Gynecology)

  • 제34권2호
  • /
  • Pages.124-141
  • /
  • 2021
  • /
  • 1229-4292(pISSN)
  • /
  • 2508-3619(eISSN)
대한한방부인과학회 (The Society of Korean Medicine Obstetrics and Gynecology)
권호 표지
DOI QR코드

DOI QR Code

지백지황환·대보음환 병용투여를 통한 성조숙증 치료에 대한 체계적 문헌고찰 및 메타분석

Jibaekjihwang-hwan and Daeboeum-hwan Combination Therapy on Precocious Puberty: a Systematic Review and Meta-Analysis

  • 강소현 (세명대학교 한의과대학 한방부인과교실) ;
  • 서지혜 (세명대학교 한의과대학 한방부인과교실) ;
  • 허다희 (세명대학교 한의과대학 한방부인과교실) ;
  • 이동녕 (세명대학교 한의과대학 한방부인과교실) ;
  • 김형준 (세명대학교 한의과대학 한방부인과교실)
  • Kang, So-Hyeon (Dept. of Korean Obstetrics and Gynecology, College of Korean Medicine, Se-Myung University) ;
  • Seo, Ji-Hye (Dept. of Korean Obstetrics and Gynecology, College of Korean Medicine, Se-Myung University) ;
  • Hur, Da-Hee (Dept. of Korean Obstetrics and Gynecology, College of Korean Medicine, Se-Myung University) ;
  • Lee, Dong-Nyung (Dept. of Korean Obstetrics and Gynecology, College of Korean Medicine, Se-Myung University) ;
  • Kim, Hyeong-Jun (Dept. of Korean Obstetrics and Gynecology, College of Korean Medicine, Se-Myung University)
  • 투고 : 2021.04.16
  • 심사 : 2021.05.28
  • 발행 : 2021.05.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: The purpose of this study is to assess the efficacy of Jibaekjihwang-hwan and Daeboeum-hwan combination therapy for the treatment of precocious puberty. Methods: 6 databases were searched from the date of inception until April 2021 for relevant studies. We included randomized controlled trials (RCTs) and non-randomized controlled trials (nRCTs) which focused on effects of Jibaekjihwang-hwan and Daeboeum-hwan on precocious puberty. Results: Total 8 literatures were included in qualitative analysis and meta analysis on results was conducted on 4 synthesizable studies. The response rate was significantly higher in Jibaekjihwang-hwan and Daeboeum-hwan combination group than in conventional therapy group. Also, serum estradiol and follicle stimulating hormone (FSH) level were significantly lower in Jibaekjihwang-hwan and Daeboeum-hwan combination group than in conventional therapy group. Conclusions: It seems that combination therapy of Jibaekjihwang-hwan and Daeboeum-hwan can effectively reduce serum estradiol and FSH level while increasing response rate significantly. Further high quality studies are needed to supplement the efficacy and safety of combination therapy of Jibaekjihwang-hwan and Daeboeum-hwan on precocious puberty.

키워드

참고문헌

  1. Korean Society of Pediatric Endocrinology: Pediatric endocrinology. 2nd ed. Seoul:Kwangmoon. 2004:176-93.
  2. Korean Society of Gynecology. Gynecology. 6th ed. Seoul:Koonja. 2021:1007-14
  3. Lee KH, et al. The Korean society of pediatric endocrinology's precocious puberty clinical guidelines. 1st ed. Seoul:Uihakmoonhwasa. 2011:18-20.
  4. Heger S, et al. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Molecular and cellular endocrinology. 2006;254-255:217-20. https://doi.org/10.1016/j.mce.2006.04.012
  5. John S. Fuqua. Treatment and Outcomes of Precocious Puberty: An Update, The Journal of Clinical Endocrinology & Metabolism. 2013;98(6):2198-207. https://doi.org/10.1210/jc.2013-1024
  6. Carel JC, et al. GnRH Analogs Consensus Conference Group. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123(4):752-62.
  7. Bouvattier C, et al. Lack of effects of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab. 1999;84(10):3575-8. https://doi.org/10.1210/jcem.84.10.6032
  8. Anik A, et al. Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty. Indian J Endocrinol Metab. 2015;19(2):267-71. https://doi.org/10.4103/2230-8210.131770
  9. Sorensen K, et al. Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression. J Clin Endocrinol Metab. 2010;95(8):3736-44. https://doi.org/10.1210/jc.2010-0731
  10. Baek JW, et al. Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty. Ann Pediatr Endocrinol Metab. 2014;19(1):27-31. https://doi.org/10.6065/apem.2014.19.1.27
  11. Kim EY. Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty. Korean journal of pediatrics. 2015;58(1):1-7. https://doi.org/10.3345/kjp.2015.58.1.1
  12. Kweon JH, et al. The Trend of Clinical Research on Treatment for Precocious Puberty - Focusing on Recent Studies in the Chinese Medical Journal CAJ -. J Pediatr Korean Med. 2017;31(1):63-73. https://doi.org/10.7778/jpkm.2017.31.1.063
  13. Yoon JG, et al. Review on the Use of Oriental Herbal Medicine for Female Idiopathic Precocious Puberty. J Korean Obstet Gynecol. 2017;30(3):20-8. https://doi.org/10.15204/JKOBGY.2017.30.3.020
  14. Lee YB, et al. Herbal Medicine for Idiopathic Central Precocious Puberty: A Systematic Review and MetaAnalysis. The Journal of Alternative and Complementary Medicine. 2020;26(11):976-99. https://doi.org/10.1089/acm.2019.0312
  15. Sun Y, Cui Z. Observation on curative effect of traditional Chinese medicine in treating exogenous precocious puberty caused by contraceptives in girls. Journal of Qiqihar Medicine. 2008;29(10):1175-6.
  16. Li C, et al. Zhibaidihuang-pill Combined With Dabuyin-pill Treatment of Children With Central Precocious Puberty: Clinical Analysis of 56Cases. Chinese Journal of Obstetrics & Gynecology and Pediatrics. 2013;9(4):504-6.
  17. Hu M, Pan W. The clinical effectiveness analysis of Zhibaidihuang-pill and Dabuyin-pill combination treatment of children with central precocious puberty. Chinese Journal of Human Sexuality. 2015;24(3):76-8.
  18. Li Z, et al. Recombinant human growth hormone improves growth deceleration in girls with idiopathic central precocious puberty treated by gonadotropin-releasing hormone analogues. Chinese Journal of Rural Medicine and Pharmacy. 2017;24(5):21-2.
  19. Zhang M. Study on the Effect of Zhibaidihuang-pill Combined with Dabuyin-pill in Treating Central Early Precocity. Chinese and Foreign Medical Research. 2017;15(29):10-1. https://doi.org/10.1186/s13020-020-0293-2
  20. Liu J, Wang H. Clinical effect and safety of Zhibaidihuang-pill combined with Dabuyin-pill in the sexual precocity of girls. Chinese Journal of Human Sexuality. 2018;27(1):64-7.
  21. Liu J, Jin M. Clinical Study on Dabuyin-pills Combined with Zhibaidihuang-pills for Precocious Puberty in Girls. Journal of New Chinese Medicine. 2020;52(7):47-50.
  22. Wang X, Li P, Feng C. Ultrasonic evaluation of clinical efficacy of Zhibai dihuang-wan combined with Dabuyin-wan on central pubertas praecox in girls. Journal of Pediatrics of Traditional Chinese Medicine. 2020;16(3):72-6. https://doi.org/10.1186/s12967-018-1437-3
  23. Kim KB, et al. Textbook of pediatrics of oriental medicine. 1st ed. Seoul:Uisungdang. 2010:852-3.
  24. Li J, Lin D, Feng G. Medication rules of traditional Chinese medicine in the treatment of children with idiopathic central precocious puberty based on data mining. Journal of Pediatrics of Traditional Chinese Medicine. 2020;06:40-5.
  25. Fu Q, et al. Systematic Review on Effectiveness and Safety of Zhibaidihuang-pills in the Adjuvant Treatment of Children's Central Precocious Puberty. Chinese Journal of Modern Applied Pharmacy. 2020;37(1):85-90.
  26. Liang J, Chen J, Ye J. Meta-analysis of the efficacy of Dabuyin-pills in the treatment of central precocious puberty in children. Strait Pharmacy. 2017;29(2):89-91.
  27. Song W, et al. Is a Combination of a GnRH Agonist and Recombinant Growth Hormone an Effective Treatment to Increase the Final Adult Height of Girls with Precocious or Early Puberty?. Int J Endocrinol. 2018;2018:1-10. Available from:URL:http://dx.doi.org/10.1155/2018/1708650.